Most Recent
Aristocrat has asked the High Court to rule once and for all on whether its popular Lightning Link game is patentable, after a differently comprised court was evenly split on the question.
IP Australia has rejected AFT Pharmaceuticals’ bid to patent a combination cold and flu medication, finding the invention was little more than putting three different medications “in a box”.
The Pakistani government's opposition to India's attempt to register a composite 'Basmati' trade mark will go on despite filing delays, with a delegate finding it was in the public interest to allow the opposition.
The patent office has rejected Visa's application to patent a token system for securing customer data, finding the process did not address a technical problem or provide a technical solution.
A GlaxoSmithKline unit has defeated Nova Pharmaceuticals' bid to trade mark 'Novadart' for a generic version of the British company's market-leading drug prostate drug 'Avodart', with a delegate finding the mark would cause consumer confusion.
US-based Dana-Farber Cancer Institute has succeeded in patenting a patient-specific method for developing cancer vaccines using genome sequencing.
IP Australia has rejected an Italian cheese lobby’s bid to block an American cheese maker from using a trade mark containing the word ‘asiago’, saying there was “very little evidence” Australians were aware of the cheese at all.
A Japanese manufacturer of musical instruments has lost its opposition to telecommunications provider Zoom's bid to register its name as a trade mark, with a delegate finding consumer confusion was unlikely given the difference in the companies' products.
Birkenstock has succeeded in securing trade mark protection for the shape of four of its shoes, a boon to the German shoe maker as it fights knock-offs of its popular sandals.
Fund manager Real Asset Management has appealed a ruling which upheld mortgage broker RAMS’ bid to block the registration of two RAM trade marks.